urea has been researched along with Tumor Lysis Syndrome in 1 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Tumor Lysis Syndrome: A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heney, D | 1 |
| Essex-Cater, A | 1 |
| Brocklebank, JT | 1 |
| Bailey, CC | 1 |
| Lewis, IJ | 1 |
1 other study available for urea and Tumor Lysis Syndrome
| Article | Year |
|---|---|
Continuous arteriovenous haemofiltration in the treatment of tumour lysis syndrome.
Topics: Child; Creatinine; Hemofiltration; Humans; Male; Phosphates; Phosphorus; Tumor Lysis Syndrome; Urea; | 1990 |